tiprankstipranks
Trending News
More News >
Cytosorbents Corp (CTSO)
NASDAQ:CTSO
US Market

Cytosorbents (CTSO) Financial Statements

Compare
485 Followers

Cytosorbents Financial Overview

Cytosorbents's market cap is currently $43.38M. The company's EPS TTM is $-0.04; its P/E ratio is -3.69; Cytosorbents is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 35.59M$ 31.08M$ 34.69M$ 40.11M$ 39.45M
Gross Profit$ 25.13M$ 21.95M$ 20.73M$ 29.06M$ 28.40M
Operating Income$ -16.79M$ -31.95M$ -31.52M$ -22.74M$ -10.37M
EBITDA$ -15.22M$ -27.88M$ -30.00M$ -21.62M$ -9.71M
Net Income$ -20.72M$ -29.25M$ -32.81M$ -24.56M$ -7.84M
Balance Sheet
Cash & Short-Term Investments$ 3.28M$ 14.13M$ 22.14M$ 52.14M$ 71.42M
Total Assets$ 47.37M$ 53.26M$ 63.23M$ 89.52M$ 89.95M
Total Debt$ 26.89M$ 18.31M$ 18.25M$ 13.82M$ 1.03M
Net Debt$ 23.61M$ 4.18M$ -3.89M$ -38.32M$ -70.39M
Total Liabilities$ 36.26M$ 29.99M$ 27.86M$ 26.94M$ 10.73M
Stockholders' Equity$ 11.11M$ 23.28M$ 35.37M$ 62.58M$ 79.22M
Cash Flow
Free Cash Flow$ -14.71M$ -22.59M$ -34.69M$ -18.29M$ -7.29M
Operating Cash Flow$ -14.43M$ -21.66M$ -28.23M$ -14.01M$ -5.61M
Investing Cash Flow$ -669.43K$ -936.24K$ -6.46M$ -4.28M$ -1.68M
Financing Cash Flow$ 9.33M$ 14.47M$ 4.96M$ 715.20K$ 66.35M
Currency in USD

Cytosorbents Earnings and Revenue History

Cytosorbents Debt to Assets

Cytosorbents Cash Flow

Cytosorbents Forecast EPS vs Actual EPS